CoreCap Advisors’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.9K Buy
2,472
+57
+2% +$1.06K ﹤0.01% 1385
2026
Q1
$39.7K Sell
2,415
-624
-21% -$10.7K ﹤0.01% 1404
2025
Q4
$48.9K Sell
3,039
-313
-9% -$5.52K ﹤0.01% 1346
2025
Q3
$64.2K Buy
3,352
+613
+22% +$11K ﹤0.01% 1214
2025
Q2
$48K Sell
2,739
-657
-19% -$11.7K ﹤0.01% 1277
2025
Q1
$68.7K Buy
3,396
+1,048
+45% +$21.2K ﹤0.01% 1037
2024
Q4
$47.6K Sell
2,348
-717
-23% -$15.5K ﹤0.01% 1196
2024
Q3
$70.1K Buy
3,065
+2,134
+229% +$46K ﹤0.01% 1057
2024
Q2
$18.2K Buy
931
+148
+19% +$2.83K ﹤0.01% 924
2024
Q1
$14.7K Buy
+783
New +$14.2K ﹤0.01% 1606
2022
Q4
$14.4K Buy
+573
New +$13.9K ﹤0.01% 1415
2022
Q3
Sell
-474
Closed -$12K 913
2022
Q2
$12K Buy
+474
New +$14.4K ﹤0.01% 1414
2022
Q1
Sell
-472
Closed -$17K 919
2021
Q4
$17K Buy
+472
New +$16.3K ﹤0.01% 1373

Other funds holding DOC

CoreCap Advisors's DOC Position: Q2 2026 in Review

CoreCap Advisors increased its Healthpeak Properties (DOC) stake by 2.4% in Q2 2026, buying an estimated $1.06K and bringing the position to 2,472 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

CoreCap Advisors first reported a position in DOC in Q4 2021 and has held it in 13 quarters since. The position peaked at $70.1K in Q3 2024. 127 funds tracked by Wall St. Rank hold DOC as of Q2 2026.

  • CoreCap Advisors held 2,472 shares of Healthpeak Properties worth $52.9K as of Q2 2026.
  • CoreCap Advisors bought 57 Healthpeak Properties shares in Q2 2026, an estimated $1.06K.
  • Healthpeak Properties made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1385 holding.
  • CoreCap Advisors first reported a position in Healthpeak Properties in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's Healthpeak Properties position peaked at $70.1K in Q3 2024.
  • 127 funds tracked by Wall St. Rank held Healthpeak Properties as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.